Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birkmayer

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Annals of Clinical and Laboratory Science|January 1, 1989
Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's diseaseW Birkmayer, G J Birkmayer
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)G J Birkmayer, W Birkmayer
Journal of Neural Transmission. Supplementum|January 1, 1986
Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experienceW Birkmayer, G D Birkmayer
Annals of Clinical and Laboratory Science|January 1, 1987
Improvement of disability and akinesia of patients with Parkinson's disease by intravenous iron substitutionJ G Birkmayer, W Birkmayer
Gerontology|January 1, 1987
Dopamine action and disorders of neurotransmitter balanceW Birkmayer, J D Birkmayer
Advances in Neurology|January 1, 1987
Current and future approaches to therapyW Birkmayer, J D Birkmayer
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Strategy and tactic of modern Parkinson therapyW Birkmayer, G J Birkmayer
Journal of Neural Transmission|January 1, 1986
Iron, a new aid in the treatment of Parkinson patientsW Birkmayer, J G Birkmayer
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Deprenyl (selegiline) in the treatment of Parkinson's diseaseW Birkmayer
Wiener Medizinische Wochenschrift (1946)|March 19, 2010
About the concept of vegetative ataxiaW BIRKMAYER
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Annals of Clinical and Laboratory Science|January 1, 1989
Nicotinamidadenindinucleotide (NADH): the new approach in the therapy of Parkinson's diseaseW Birkmayer, G J Birkmayer
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)G J Birkmayer, W Birkmayer
Journal of Neural Transmission. Supplementum|January 1, 1986
Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experienceW Birkmayer, G D Birkmayer
Annals of Clinical and Laboratory Science|January 1, 1987
Improvement of disability and akinesia of patients with Parkinson's disease by intravenous iron substitutionJ G Birkmayer, W Birkmayer
Gerontology|January 1, 1987
Dopamine action and disorders of neurotransmitter balanceW Birkmayer, J D Birkmayer
Advances in Neurology|January 1, 1987
Current and future approaches to therapyW Birkmayer, J D Birkmayer
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Strategy and tactic of modern Parkinson therapyW Birkmayer, G J Birkmayer
Journal of Neural Transmission|January 1, 1986
Iron, a new aid in the treatment of Parkinson patientsW Birkmayer, J G Birkmayer
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Deprenyl (selegiline) in the treatment of Parkinson's diseaseW Birkmayer
Wiener Medizinische Wochenschrift (1946)|March 19, 2010
About the concept of vegetative ataxiaW BIRKMAYER
Pageof 14